Chiang, Jeremy Chung Bo https://orcid.org/0000-0002-6133-7411
Wu, Mengliang https://orcid.org/0000-0002-0142-6623
Lee, Ji-Hyun
Curkpatrick, Alyssa
Ifantides, Cristos https://orcid.org/0000-0003-2289-6656
Nguyen, Thanh https://orcid.org/0000-0002-0177-4230
Galor, Anat https://orcid.org/0000-0002-3026-6155
Wu, Helen
Lindstrom, Richard https://orcid.org/0000-0002-7935-9512
Thompson, Vance
Downie, Laura E. https://orcid.org/0000-0002-1596-2259
Clinical trials referenced in this document:
Documents that mention this clinical trial
Impact of an Ophthalmic Cooling Device on Corneal Immune and Sensory Nerve Features in Chronic Ocular Surface Pain: A Prospective, Feasibility Study
https://doi.org/10.1007/s40123-026-01454-6
Article History
Received: 1 June 2026
Accepted: 26 June 2026
First Online: 15 July 2026
Declarations
Conflict of Interest: Jeremy Chung Bo Chiang: none; Mengliang Wu: the University of Melbourne, provisional patent to protect Fun-IVCM imaging technique (AU2023901150) (P, Patent—ongoing); Ji-hyun Lee: none; Alyssa Curkpatrick: none; Cristos Ifantides: EyeCool Therapeutics (C, Consultant—ongoing); Thanh Nguyen: EyeCool Therapeutics (F, Financial Support—ongoing); Anat Galor: EyeCool Therapeutics (C, Consultant—ongoing); Helen Wu: None; Richard Lindstrom: EyeCool Therapeutics (C, Consultant—ongoing); Vance Thompson: EyeCool Therapeutics (C, Consultant—ongoing); and Laura E. Downie: the University of Melbourne, provisional patent to protect Fun-IVCM imaging technique (AU2023901150) (P, Patent—ongoing), EyeCool Therapeutics (F, Financial Support—ongoing).
Ethical Approval: The study was approved by the Human Research Ethics Committee of St Vincent’s Hospital (085/25), was registered prospectively with ClinicalTrials.gov (NCT07059754), and adhered to the tenets of the Declaration of Helsinki. Participants provided written informed consent to participate after a comprehensive explanation about the study.